Aberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients

ArticleAçık Erişim

Özet

Ovarian cancer (OC) ranks as the eighth most prevalent malignancy among women globally. The short non-coding RNA molecules, microRNAs (miRNAs) target multiple mRNAs and regulate the gene expression. Here in this study, we aimed to validate miR-3135b and miR-1273g-3p as novel biomarkers for prognostic and diagnostic factor OC. After RNA isolation, we analyzed the miR-3135b and miR-1273g-3p expression in peripheral blood samples derived from 150 OC patients. Subsequently, we compared their expression levels with 100 healthy controls. The differences of miR-3135b and miR-1273g-3p expression were detected using the Quantitative Real Time-PCR (qRT-PCR) technique following miRNA-specific cDNA synthesis pursing miRNA separation. The miR-3135b and miR-1273g-3p were higher in OC patients who tested positive for BRCA1/2 compared to BRCA-negative patients, and healthy cases. The level of miR-3135b demonstrated a roughly 4.82-fold increase in OC patients in comparison to the healthy cases, while miR-1273g-3p expression exhibited a roughly 6.77-fold increase. The receiver operating characteristic (ROC) analysis has demonstrated the potential of miR-3135b and miR-1273g-3p as markers for distinguishing between OC patients and healthy controls. The higher expressions of miR-3135b and miR-1273g-3p could be associated with OC development. Moreover, miR-3135b may have a diagnostic potential and miR-1273g-3p may have both diagnostic and prognostic potential in OC cell differentiation. The string analysis has revealed an association between miR-1273g-3p and the MDM2 gene, suggesting a potential link to tumor formation through the proteasomal degradation of the TP53 tumor suppressor gene. Additionally, the analysis indicates an association of miR-1273g-3p with CHEK1, a gene involved in checkpoint-mediated cell cycle arrest. String analysis also indicates that miR-3135b is associated with the MAPK1 gene, causing activation of the oncogenesis cascade. In conclusion, miR-1273g-3p, and miR-3135b exhibit significant potential as diagnostic markers. However, further research is needed to comprehensively investigate these miRNAs diagnostic and predictive characteristics in a larger cohort. © 2023 The Authors

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11530Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTuncer, Seref Bugra
dc.contributor.authorCelik, Betul
dc.contributor.authorKılıc Erciyas, Seda
dc.contributor.authorSukruoglu Erdogan, Ozge
dc.contributor.authorPasin, Ozge
dc.contributor.authorAvsar, Mukaddes
dc.contributor.authorKurt Gultaslar, Busra
dc.contributor.authorAdamnejad Ghafour, Arash
dc.contributor.authorUyaroglu, Gamze
dc.contributor.authorAkdeniz Odemis, Demet
dc.contributor.authorYazıcı, Hulya
dc.date.accessioned2026-10-18T20:26:34.137230767Z
dc.date.available2026-10-18T20:26:34.137230767Z
dc.date.issued2024
dc.description.abstractOvarian cancer (OC) ranks as the eighth most prevalent malignancy among women globally. The short non-coding RNA molecules, microRNAs (miRNAs) target multiple mRNAs and regulate the gene expression. Here in this study, we aimed to validate miR-3135b and miR-1273g-3p as novel biomarkers for prognostic and diagnostic factor OC. After RNA isolation, we analyzed the miR-3135b and miR-1273g-3p expression in peripheral blood samples derived from 150 OC patients. Subsequently, we compared their expression levels with 100 healthy controls. The differences of miR-3135b and miR-1273g-3p expression were detected using the Quantitative Real Time-PCR (qRT-PCR) technique following miRNA-specific cDNA synthesis pursing miRNA separation. The miR-3135b and miR-1273g-3p were higher in OC patients who tested positive for BRCA1/2 compared to BRCA-negative patients, and healthy cases. The level of miR-3135b demonstrated a roughly 4.82-fold increase in OC patients in comparison to the healthy cases, while miR-1273g-3p expression exhibited a roughly 6.77-fold increase. The receiver operating characteristic (ROC) analysis has demonstrated the potential of miR-3135b and miR-1273g-3p as markers for distinguishing between OC patients and healthy controls. The higher expressions of miR-3135b and miR-1273g-3p could be associated with OC development. Moreover, miR-3135b may have a diagnostic potential and miR-1273g-3p may have both diagnostic and prognostic potential in OC cell differentiation. The string analysis has revealed an association between miR-1273g-3p and the MDM2 gene, suggesting a potential link to tumor formation through the proteasomal degradation of the TP53 tumor suppressor gene. Additionally, the analysis indicates an association of miR-1273g-3p with CHEK1, a gene involved in checkpoint-mediated cell cycle arrest. String analysis also indicates that miR-3135b is associated with the MAPK1 gene, causing activation of the oncogenesis cascade. In conclusion, miR-1273g-3p, and miR-3135b exhibit significant potential as diagnostic markers. However, further research is needed to comprehensively investigate these miRNAs diagnostic and predictive characteristics in a larger cohort. © 2023 The Authors
dc.description.sponsorshipWe would like to express our gratitude to the Oncology Institute of Istanbul University for their support and resources throughout this study. We thank all contributors who have helped in carrying out the research in Cancer Genetic Departments. No specific grants from funding agencies in the commercial sectors were received for this research.
dc.identifier.doi10.1016/j.heliyon.2023.e23876
dc.identifier.eissn2405-8440
dc.identifier.issn2405-8440
dc.identifier.issue1
dc.identifier.pmcidPMC10792459
dc.identifier.pmid38234891
dc.identifier.scopus2-s2.0-85182420260
dc.identifier.startpagee23876
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11530
dc.identifier.volume10
dc.identifier.wosWOS:001166116100001
dc.language.isoen
dc.publisherElsevier Ltd
dc.relation.ispartofHeliyon
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBiomarker
dc.subjectmiR-1273g-3p
dc.subjectMir-3135b
dc.subjectmiRNA
dc.subjectOvarian cancer
dc.titleAberrant miR-3135b and miR-1273g-3p expression in the peripheral blood samples of BRCA1/2 (±) ovarian cancer patients
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus4
rdl.citation.wos3
rdl.departmentMolecular Biology Department, Erzincan Binali Yıldırım University, Erzincan, Türkiye.
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)